ABEO logo

Abeona Therapeutics (ABEO) Return On Equity

Annual ROE

-260.60%
-145.75%-126.90%

December 31, 2023


Summary


Performance

ABEO ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABEOprofitabilitymetrics:

Quarterly ROE

-227.38%
-19.53%-9.40%

September 30, 2024


Summary


Performance

ABEO Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABEOprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

ABEO ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-126.9%0.0%
3 y3 years-334.6%-300.2%
5 y5 years-599.2%-255.9%

ABEO ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-126.9%at low-115.8%+72.3%
5 y5-year-433.8%at low-393.8%+72.3%
alltimeall time-192.7%+91.8%-122.1%+78.7%

Abeona Therapeutics ROE History

DateAnnualQuarterly
Sep 2024
-
-227.38%(+9.4%)
Jun 2024
-
-207.85%(-74.7%)
Mar 2024
-
-821.46%(+146.1%)
Dec 2023
-260.60%(+126.9%)
-333.73%(+43.4%)
Sep 2023
-
-232.65%(+6.9%)
Jun 2023
-
-217.59%(+82.9%)
Mar 2023
-
-118.99%(-18.4%)
Dec 2022
-114.85%(-2.0%)
-145.87%(-30.4%)
Sep 2022
-
-209.62%(+35.3%)
Jun 2022
-
-154.95%(+13.1%)
Mar 2022
-
-137.00%(+30.1%)
Dec 2021
-117.22%(+95.5%)
-105.34%(+85.4%)
Sep 2021
-
-56.82%(+8.3%)
Jun 2021
-
-52.47%(+13.9%)
Mar 2021
-
-46.05%(-29.0%)
Dec 2020
-59.96%(+22.8%)
-64.84%(-1.7%)
Sep 2020
-
-65.97%(-11.8%)
Jun 2020
-
-74.77%(-10.8%)
Mar 2020
-
-83.80%(+39.2%)
Dec 2019
-48.82%(+31.0%)
-60.21%(-5.7%)
Sep 2019
-
-63.88%(+12.1%)
Jun 2019
-
-56.98%(+29.0%)
Mar 2019
-
-44.18%(+22.3%)
Dec 2018
-37.27%(+83.6%)
-36.12%(+12.2%)
Sep 2018
-
-32.18%(+19.5%)
Jun 2018
-
-26.92%(+1.4%)
Mar 2018
-
-26.55%(+5.7%)
Dec 2017
-20.30%(-22.6%)
-25.12%(-15.1%)
Sep 2017
-
-29.58%(+4.5%)
Jun 2017
-
-28.31%(+1.1%)
Mar 2017
-
-27.99%(-8.5%)
Dec 2016
-26.22%(-34.5%)
-30.60%(+17.8%)
Sep 2016
-
-25.97%(-17.6%)
Jun 2016
-
-31.51%(-6.0%)
Mar 2016
-
-33.52%(-3.7%)
Dec 2015
-40.05%(-92.8%)
-34.80%(-68.1%)
Sep 2015
-
-109.04%(-89.8%)
Jun 2015
-
-1064.96%(-584.3%)
Mar 2015
-
219.91%(+42.6%)
Dec 2014
-556.02%(+1747.2%)
154.26%(+115.8%)
Sep 2014
-
71.48%(-12.1%)
Jun 2014
-
81.28%(+2209.1%)
Mar 2014
-
3.52%(-110.7%)
Dec 2013
-30.10%(-148.8%)
-33.02%(-81.7%)
Sep 2013
-
-180.44%(+278.7%)
Jun 2013
-
-47.65%(-925.8%)
Mar 2013
-
5.77%(-84.3%)
Dec 2012
61.68%(+328.9%)
36.76%(-64.8%)
Sep 2012
-
104.50%(+62.3%)
Jun 2012
-
64.40%(+148.2%)
Mar 2012
-
25.95%(+124.7%)
Dec 2011
14.38%
11.55%(+415.6%)
Sep 2011
-
2.24%(-96.0%)
DateAnnualQuarterly
Jun 2011
-
55.49%(+21.2%)
Mar 2011
-
45.80%(+36.1%)
Dec 2010
36.24%(-43.6%)
33.66%(-57.2%)
Sep 2010
-
78.59%(+56.4%)
Jun 2010
-
50.26%(-31.9%)
Mar 2010
-
73.82%(-27.2%)
Dec 2009
64.25%(-77.1%)
101.43%(+27.4%)
Sep 2009
-
79.60%(-15.9%)
Jun 2009
-
94.69%(-22.4%)
Mar 2009
-
122.06%(-61.8%)
Dec 2008
280.99%(-108.8%)
319.88%(-68.9%)
Sep 2008
-
1027.71%(+99.6%)
Jun 2008
-
515.01%(+52.6%)
Mar 2008
-
337.43%(+77.4%)
Dec 2007
-3192.95%(-2552.2%)
190.18%(+146.4%)
Sep 2007
-
77.19%(-5.8%)
Jun 2007
-
81.96%(-15.5%)
Mar 2007
-
97.04%(-14.6%)
Dec 2006
130.21%(+224.6%)
113.64%(+211.8%)
Sep 2006
-
36.45%(-4.0%)
Jun 2006
-
37.95%(-11.2%)
Mar 2006
-
42.72%(+140.1%)
Dec 2005
40.12%(-73.9%)
17.79%(-83.9%)
Sep 2005
-
110.17%(-25.4%)
Jun 2005
-
147.69%(-26.5%)
Mar 2005
-
200.97%(-45.9%)
Dec 2004
153.70%(+29.1%)
371.55%(-5.1%)
Sep 2004
-
391.36%(-0.6%)
Jun 2004
-
393.90%(+39.2%)
Mar 2004
-
282.95%(+28.0%)
Dec 2003
119.06%(-160.7%)
221.07%(-48.2%)
Sep 2003
-
426.88%(-167.4%)
Jun 2003
-
-633.13%(+92.2%)
Mar 2003
-
-329.34%(+82.7%)
Dec 2002
-196.17%(+291.9%)
-180.27%(+51.2%)
Sep 2002
-
-119.21%(+45.1%)
Jun 2002
-
-82.13%(+31.8%)
Mar 2002
-
-62.30%(+26.1%)
Dec 2001
-50.05%(-14.2%)
-49.41%(+12.2%)
Sep 2001
-
-44.05%(+15.7%)
Jun 2001
-
-38.06%(+3.3%)
Mar 2001
-
-36.85%(-12.3%)
Dec 2000
-58.35%(-52.4%)
-42.01%(-4.3%)
Sep 2000
-
-43.90%(-19.3%)
Jun 2000
-
-54.42%(-29.3%)
Mar 2000
-
-76.98%(-44.8%)
Dec 1999
-122.52%(-56.8%)
-139.52%(+14.0%)
Sep 1999
-
-122.37%(-47.9%)
Jun 1999
-
-234.97%(+206.3%)
Mar 1999
-
-76.70%
Dec 1998
-283.45%(+48.7%)
-
Dec 1997
-190.64%(-52.2%)
-
Dec 1996
-398.96%(-2072.1%)
-
Dec 1995
20.23%
-

FAQ

  • What is Abeona Therapeutics annual return on equity?
  • What is the all time high annual ROE for Abeona Therapeutics?
  • What is Abeona Therapeutics annual ROE year-on-year change?
  • What is Abeona Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for Abeona Therapeutics?
  • What is Abeona Therapeutics quarterly ROE year-on-year change?

What is Abeona Therapeutics annual return on equity?

The current annual ROE of ABEO is -260.60%

What is the all time high annual ROE for Abeona Therapeutics?

Abeona Therapeutics all-time high annual return on equity is 280.99%

What is Abeona Therapeutics annual ROE year-on-year change?

Over the past year, ABEO annual return on equity has changed by -145.75% (-126.90%)

What is Abeona Therapeutics quarterly return on equity?

The current quarterly ROE of ABEO is -227.38%

What is the all time high quarterly ROE for Abeona Therapeutics?

Abeona Therapeutics all-time high quarterly return on equity is 1027.71%

What is Abeona Therapeutics quarterly ROE year-on-year change?

Over the past year, ABEO quarterly return on equity has changed by 0.00% (0.00%)